Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells. (2023)

First Author: Inaba A
Attributed to:  Low dose interleukin (IL)-2 in patients with a recent acute coronary syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.95462

Publication URI: https://www.repository.cam.ac.uk/handle/1810/348044

Type: Journal Article/Review